NASDAQ:BGNE
BeiGene Ltd Stock News
$172.85
+1.82 (+1.06%)
At Close: May 17, 2024
BeiGene Receives Positive CHMP Opinion for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
05:00am, Monday, 26'th Feb 2024
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $BGNE #BeiGene--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committ
Get Rich Quick With These 3 Biotech Stocks to Buy Now
12:58pm, Tuesday, 13'th Feb 2024
I have always said it, and I keep my word regarding the biotechnology sector, since it is one of the largest and most important sectors. Not only is it vital for the financial markets, but for the qua
BeiGene: Debating On Finally Establishing A Position
08:25am, Friday, 26'th Jan 2024
The company's recent pipeline advancements and successful clinical trials have reduced its valuation and made it more attractive.
BeiGene Welcomes Experienced Life Sciences Executive Olivier Brandicourt to Board of Directors
06:00am, Tuesday, 23'rd Jan 2024
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $BGNE #BeiGene--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that Olivie
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond
06:30am, Monday, 15'th Jan 2024
Biotech has been out of favor among investors for over two years. The sector could be on the verge of a trend reversal because of multiple tailwinds.
3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024
11:18am, Friday, 05'th Jan 2024
REGN, BGNE & SRPT are three biotech companies that are likely to outperform the sector on the back of strong fundamentals.
Top 5 Momentum Picks for January After a Fabulous 2023
09:46am, Wednesday, 03'rd Jan 2024
We have narrowed our search to five large-cap stocks that have strong momentum for January. These are BGNE, SHOP, REGN, SPLK and CASY.
New Strong Buy Stocks for December 22nd
08:16am, Friday, 22'nd Dec 2023
DOYU, STLA, BGNE, LEGH and WTS have been added to the Zacks Rank #1 (Strong Buy) List on December 22, 2023.
3 Cancer-Focused Biotechs That Appear Promising Bets for 2024
10:32am, Thursday, 21'st Dec 2023
With the spotlight on oncology-focused companies in the biotech sector in 2023, we discuss three stocks that have a promising oncology portfolio/pipeline for 2024.
BeiGene to Present at the 42nd Annual J.P. Morgan Healthcare Conference
06:01am, Thursday, 21'st Dec 2023
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $BGNE #BeiGene--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Co
5 Nasdaq Composite Laggards Likely to Gather Pace in 2024
09:47am, Tuesday, 19'th Dec 2023
We have narrowed our search to five Nasdaq Composite listed laggards of 2023 with strong potential for 2024. These are: PEP, KHC, WMG, PODD, BGNE.
BeiGene to Host ASH Investor Meeting in Person and via Webcast on December 10, 2023
04:01pm, Wednesday, 29'th Nov 2023
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $BGNE #BeiGene--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that it wil
BeiGene to Present New Data Highlighting Hematology Portfolio and Pipeline Strengths at ASH 2023
06:00am, Tuesday, 28'th Nov 2023
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $BGNE #BeiGene--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the present
BeiGene agrees to acquire Ensem Therapeutics' cancer therapy
06:19am, Tuesday, 21'st Nov 2023
BeiGene said on Tuesday it has entered into an agreement with biotech company Ensem Therapeutics to acquire a global license for a cancer therapy that is ready to enter early-stage trial.
5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024
09:46am, Monday, 20'th Nov 2023
We have narrowed our search to five biotech stocks with strong potential for 2024. These are: LEGN, BGNE, GILD, EXAS, SRPT.
